Johnson & Johnson’s destiny choice will certainly be revealed soon. At the same time, Genmab is getting ready for the future with enhanced financial investments in late-stage programs with 3 lead prospects.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/genmab-chief-crucial-jj-decision-doesnt-change-strategy/